Low symptomatic COVID-19 in an elderly patient with follicular lymphoma treated with rituximab-based immunotherapy: A case report.

World J Clin Cases · 2021 · PMC8223830 · PMID 34222459

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

This case highlights that rituximab-based therapy may have no evident negative effect on the clinical course of COVID-19 in patients with follicular lymphoma, which may be significant during the current pandemic.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.